:

Given the evolving healthcare ecosystem, many pharmaceutical and biotech organizations seek to accelerate speed to market while reducing risk throughout the development lifecycle. From AI approaches applied in drug discovery to data-driven strategy and omnichannel engagement, Slalom can help support your efforts from bench to bedside.

The pandemic highlighted significant challenges in the global supply chain, particularly in the life sciences space. In response, organizations have turned to strategic approaches to operations, manufacturing, and automation. We can help you identify, prioritize, and realize a more resilient—and compliant—supply chain.

As the technologies supporting cell and gene therapies continue to evolve rapidly, many organizations are pressured to move with speed despite regulatory hurdles. Slalom can help support your growth goals by optimizing your processes, people, and technologies, from supply chain to provider and patient experience.

As the industry embraces emerging technologies to emphasize value-based care and improve patient experience, many organizations are asked to innovate both rapidly and efficiently. We can bring our intelligent products approach to help you integrate cutting-edge technology while delivering compliant, reliable, and seamless patient and provider experiences.

Pharma and biotech companies are demanding more holistic and multi-modal data of higher value from clinical and real-world sources with clear provenance, completeness, and quality to inform drug discovery and commercial strategy. We partner with you to identify the technologies and processes necessary to deliver.